Vedan Int'l (02317) announced its interim results for the six months ended June 30, 2025. The group recorded revenue of $184 million, representing a decrease of 0.48% year-over-year. Profit attributable to owners of the company reached $7.598 million, down 8.8% compared to the same period last year. Basic earnings per share stood at 0.5 US cents. The company proposes to distribute an interim dividend of 0.3 US cents per share.

According to the announcement, the revenue decline was primarily attributed to intensifying competition across various markets. Among the group's main products, monosodium glutamate (MSG) experienced lower selling prices and revenue due to weakened consumer market demand and increased competition. Despite lower raw material and energy costs compared to the previous year, market competition continued to pressure gross profit margins below last year's levels.

For modified starch products, overcapacity in Thailand led to market price reductions. While the group maintained relatively higher prices, this resulted in decreased sales volume and revenue. However, lower raw material prices compared to the same period last year helped increase gross profit year-over-year.

Specialty products continued to face weak demand amid economic downturn and competitive pressures. The group lowered prices to maintain sales volume, resulting in slightly reduced revenue compared to the previous year.

Hydrochloric acid was affected by sluggish market demand, with average selling prices continuing to decline, leading to reduced revenue compared to the previous year. Although raw material and energy costs decreased slightly, gross profit still declined year-over-year.

For fertilizer and feed products, the company actively developed other product categories to address market competition and weak demand.

Additionally, among the group's other products, coffee and bulk food ingredients saw increased revenue compared to the previous year due to price improvements and sustained demand.